| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |